Canada Insulin Pump & CGM Market Report 2018: A Potential

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
717
Canada Insulin Pump & CGM Market Report 2018: A Potential CAD 1 Billion Market by 2024

Dublin, June 06, 2018 (GLOBE NEWSWIRE) -- The "Canada Insulin Pump & CGM Market, Users, Reimbursement Policy (Government & Companies), Distribution Model, Training Model, Pricing Landscape, Diabetes, Diabetes (Type1 & 2) Population" report has been added to ResearchAndMarkets.com's offering.

Although Canada insulin pump market is small, it has market potential to reach nearly CAD 1 Billion mark by the end of the year 2024

Similarly CGM market is also small but if it gets reimbursement under Canadian government then it has market potential to surpass CAD 80 Million by 2024. The government of Canada has expanded its diabetes management policy along with diabetes technology which will further boost the market for both insulin pump and continuous glucose monitoring (CGM) devices in Canada. Canada Insulin Dependent User: In this report, we have done a comprehensive analysis of insulin dependent users suffering from Type 1 Diabetes and Type 2 Diabetes. It includes all types of insulin whether it is single insulin syringe, multiple daily injections, insulin pen or an insulin pump. Canada Insulin Pump User & Market:

We have done in-depth analysis of insulin pump user and its market projection. In a similar way, we have also covered potential insulin pump users in Canada and its market & forecast. Canada CGM (Continuous Glucose Monitoring) Device User & Market: The report covers CGM User, Market & Forecast. It also covers potential CGM Users in Canada and its market & forecast. In addition, we have also studied, what are the reimbursement policies of CGM device in Canada and how the Canadian national healthcare institution are watching CGM assessment over the period of time. By Province & Private Insurers - Canada Insulin Pump Reimbursement Policy: The study captures detailed analysis of insulin pump reimbursement policy of all 11 provinces. In Canada, insulin pump is reimbursed by provincial healthcare provider under the ministry of health. Each province provides their own insulin pump program to its citizen. Moreover, we have covered 11 provincial insulin pump programs with procedure and detailed information. In addition there are many private insurers which also provide insulin pump reimbursement in Canada. We have covered 5 Private Insurer Reimbursement policies. All the 5 private insurers covered in the report are as follows: Sun Life Financial Great-West Life Assurance Company, Medavie Blue Cross, Green Shield Canada, & Manulife Financial. Canada Insulin Pump Distribution Model Analysis: We have done a detailed analysis of distribution model of an insulin pump and associated supplies. This report will explain everything about manufacturer and registered vender of the insulin pump in Canada and their roles in supply chain distribution. Training Model Analysis: The report has done a complete analysis of diabetes training modules which are provided to the healthcare professional and patients. The report through graphs has shown the complete sequence of the training procedure.

This latest study Canada Insulin Pump & CGM Market, Users, Reimbursement Policy (Government & Companies), Distribution Model, Training Model, Pricing Landscape, Diabetes, Diabetes (Type1 & 2) Population provides a detailed and comprehensive insight of the Canada Insulin Pump Market.

  • Insulin User (2010 - 2024)
  • Insulin Dependent User (Type 1 & Type Diabetes)
  • Insulin Pump User
  • CGM (Continuous Glucose Monitoring) User
  • Market (2010 - 2024) - Actual & Potential

Insulin Pump Market:

CGM (Continuous Glucose Monitoring) Market:

A. Actual Market is the current market which is already present B. Potential Market is the market which can be achieved, but it has yet not been achieved due to reimbursement policies.

Key Topics Covered:

1. Executive Summary 2. Diabetes Population (2010 - 2024) 2.1 Diabetes Cost on Canada Healthcare System 2.2 Total Diabetes Population 2.2.1 Type 1 Diabetes Population 2.2.2 Type 2 Diabetes Population 2.3 Insulin Dependent Diabetes Population 3. Insulin Pump Users & Continuous Glucose Monitoring (CGM) Users (2010 - 2024) 3.1 Insulin Pump Users (2010 - 2024) 3.2 Potential Insulin Pump User 3.3 CGM (Continuous Glucose Monitoring) User 3.4 Potential CGM Users (2010 - 2024) 4. Market Size & Projections (2010 - 2024) 4.1 Insulin Pump Market 4.2 Potential Insulin Pump Market 4.3 CGM Market & Forecast 4.4 Glucose Sensor Market & Forecast 4.5 CGM Transmitter Market & Forecast 4.6 Potential CGM Market 5. Competitive Analysis - Local Insights Sales, Marketing Structure & Promotional Activities (2016 - 2017) 5.1 Medtronic in Canada 5.2 Animas in Canada 5.3 OmniPod (Insulet Corporation) in Canada 6. Distribution Models 6.1.1 Distribution Model of Insulin Pump in Canada via Canadian Province 7. Differentiation Points of Insulin Pump Products in Canada 8. Training Model (Medtronic, Animas and Insulet Corp Training to Patients & HCP) 8.1 Medtronic 8.1.1 Training Guidelines for Insulin Pump Therapy to New Patients 8.1.2 Training Model for HCP (HealthCare Professional) 8.2 Insulet Canada Corporation (OmniPod) 8.2.1 Training Structure for New Patients - Insulet Canada Corporation (OmniPod) 8.2.2 Training Model for Health Care Professional - Insulet Canada Corporation (OmniPod) 8.3 Animas Corporation Canada 8.3.1 Training Modules for New Patients 8.3.2 Training Modules for HCP (Health Care Professional) 9. Current Struggles 9.1 Animas 9.2 Medtronic 9.3 Insulet Corporation 10. Pricing Landscape & Reimbursement (Insulin Pump, Insulin Pump + CGM, CGM) 10.1 Manufacturers - Pricing (By product) 10.2 Insulin Pump Integrated with CGM 10.3 Abbott Libre - Personal (if known) vs Professional use 11. Payers - Canada Pricing and Reimbursement Policies 11.1 Public Reimbursement details by Province 11.2 Eligibility Criteria for Coverage and Limitations 11.2.1 Alberta Health Service Insulin Pump Therapy Program Eligibility Criteria 11.2.2 British Columbia Insulin Pump Therapy Program Eligibility Criteria 11.2.3 Ontario Insulin Pump Therapy Program (Assistive Devices Program) Eligibility Criteria 11.2.4 Saskatchewan Insulin Pump Program Eligibility Criteria 11.2.5 Prince Edward Island Insulin Pump Program Eligibility Criteria 11.3 Canada All Provinces Insulin Pump Program Eligibility Criteria 11.4 Coverage for Supplies per Piece (Quantity Limits, $ Limits, Frequency Limits) 12. Top 5 Canadian Private Insurers Reimbursement Details 12.1 Great-West Life Assurance Company 12.2 Sun Life Financial 12.3 Medavie Blue Cross 12.4 Green Shield Canada 12.5 Manulife Financial

For more information about this report visit https://www.researchandmarkets.com/research/j...sulin?w=12

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Diabetes Devices , Infusions and Injectables , Endocrinology

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 37

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 58

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

Bill Gates' Crossroads: Choosing Microsoft Over Harvard

Updated Category News Views 113

Bill Gates' Pivotal Decision Bill Gates, the co-founder of Microsoft, embarked on an intense journey during the early days of his company. Initially, he aimed to balance the demands of his blossoming software business with his studies at Harvard University. However, as the pressure mounted, he encountered a crucial decision that would shape his future. Struggling Between...

Continue Reading
Ensurge Micropower Invites Shareholders to Subscribe for New Shares

Updated Category News Views 63

Ensurge Micropower Announces Final Day for Share Subscription Ensurge Micropower ASA, known for its groundbreaking advancements in microbattery technology, has set the stage for a significant opportunity for shareholders. The subscription period for its subsequent offering, which consists of up to 22,222,222 new shares, is coming to a close. For those interested in...

Continue Reading
MongoDB Faces Class Action for Alleged Securities Violations

Updated Category News Views 57

Legal Challenges Facing MongoDB, Inc. MongoDB, Inc. (“MongoDB” or “the Company”) is currently embroiled in a class action lawsuit concerning alleged breaches of securities laws. This situation has sparked considerable concern among shareholders and investors about the company's transparency and the reliability of its financial practices. Overview of Allegations...

Continue Reading
Leading Edge Materials Updates Investors on Private Placement

Updated Category News Views 144

Leading Edge Materials Provides Update on Private Placement Leading Edge Materials Corp. (TSXV: LEM) has shared a significant update regarding its previously announced non-brokered private placement. This update is crucial for investors and stakeholders to understand the current status of the financing effort made by the company. The announcement clarifies that, as of the...

Continue Reading
Honoring Excellence in Community Development Financing Innovations

Updated Category News Views 214

Recognizing Leaders in Community Development Finance The Opportunity Honors bring attention to remarkable individuals and organizations shaping communities through dedicated efforts in community development finance. These awards shine a light on those who are committed to fostering economic growth and opportunity for all. Acknowledging the Contributions of Key Figures At...

Continue Reading